In the BioHarmony Drug Report Database

"Preview" Icon

Conivaptan

Vaprisol (conivaptan) is a small molecule pharmaceutical. Conivaptan was first approved as Vaprisol on 2005-12-29. It is used to treat hyponatremia in the USA. The pharmaceutical is active against vasopressin V1a receptor and vasopressin V2 receptor.

 

Trade Name

 

Vaprisol, Vaprisol In Dextrose
 

Common Name

 

conivaptan
 

ChEMBL ID

 

CHEMBL1755
 

Indication

 

hyponatremia
 

Drug Class

 

Vasopressin receptor antagonists

Image (chem structure or protein)

Conivaptan structure rendering